Reaction
Pericarditis Constrictive reporting signals
As of the last recalculation, Pericarditis Constrictive appears in 409 FAERS reports alongside 9 co-occurring drug terms. The strongest observed disproportionality signal is VALGANCICLOVIR HYDROCHLORIDE POWDER, (PRR 56.0).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Valganciclovir Hydrochloride Powder, | 13 | 56.0 | 56.0 |
| Basiliximab | 11 | 48.9 | 48.9 |
| Valganciclovir | 17 | 47.8 | 47.9 |
| Valganciclovir Hydrochloride | 17 | 47.8 | 47.9 |
| Colchicine | 21 | 42.7 | 42.8 |
| Sirolimus | 10 | 38.7 | 38.7 |
| Busulfan | 8 | 26.4 | 26.4 |
| Bleomycin Sulfate | 5 | 24.9 | 24.9 |
| Bosutinib | 3 | 17.1 | 17.1 |